• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VENITI, INC. VICI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VENITI, INC. VICI Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypersensitivity/Allergic reaction (1907); Inflammation (1932); Pain (1994); Swelling (2091)
Event Date 07/01/2019
Event Type  Injury  
Manufacturer Narrative
Date of event.The event date was not provided.The first date of the month of the aware date was selected.
 
Event Description
It was reported that the patient experienced pain, swelling, inflammation and an allergic reaction.A vici iliac stent was implanted.Immediately following the implantation, the patient had an onset of increased pain.The pain was severe cramping in the pelvic area.It was noted that there was swelling and inflammation around the stent itself.Plavix was prescribed.A couple of weeks after the stent was implanted, the patient developed a terrible rash over the entire body.The patient discontinued the use of plavix and was given huge doses of steroids.The steroids made the rash go away.Rough skin was noted where the rash used to be.Multiple doses of steroids have been given to the patient since the rash went away.The patient experiences terrible pelvic cramping similar to labor pains, unless anti-inflammatory medications are taken.The patient is generally tired, has no energy and basically just feels terrible.None of these symptoms were present prior to the stent being implanted.The patient presented with leg pain; however the stent itself did not fix the leg pain, in fact it just became worse after the stent was implanted.The patient was tested to determine the source of the reactions, and the patient was found to be reactive or hypersensitive to titanium.Further testing was requested by the patient to determine if the reactions are related to the stent material.
 
Manufacturer Narrative
B3: date of event.The event date was not provided.The first date of the month of the aware date was selected.
 
Event Description
This event was further reported via a voluntary medwatch #mw5092575.It was reported that the patient experienced pain, swelling, inflammation and an allergic reaction.A vici iliac stent was implanted.Immediately following the implantation, the patient had an onset of increased pain.The pain was severe cramping in the pelvic area.It was noted that there was swelling and inflammation around the stent itself.Plavix was prescribed.A couple of weeks after the stent was implanted, the patient developed a terrible rash over the entire body.The patient discontinued the use of plavix and was given huge doses of steroids.The steroids made the rash go away.Rough skin was noted where the rash used to be.Multiple doses of steroids have been given to the patient since the rash went away.The patient experiences terrible pelvic cramping similar to labor pains, unless anti-inflammatory medications are taken.The patient is generally tired, has no energy and basically just feels terrible.None of these symptoms were present prior to the stent being implanted.The patient presented with leg pain; however the stent itself did not fix the leg pain, in fact it just became worse after the stent was implanted.The patient was tested to determine the source of the reactions, and the patient was found to be reactive or hypersensitive to titanium.Further testing was requested by the patient to determine if the reactions are related to the stent material.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICI
Manufacturer (Section D)
VENITI, INC.
4025 clipper court
fremont CA 94538
MDR Report Key9643615
MDR Text Key177048231
Report Number2134265-2020-00626
Device Sequence Number1
Product Code QAN
Combination Product (y/n)N
PMA/PMN Number
QAN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup
Report Date 03/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received02/11/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
-
-